Conferences - Results from #7920

TAT-10: A Novel Micro-Actinium225-Bismuth212 Biomedical Generator System June 21, 2017

TAT-10: US DOE Tri-Lab Research Effort to Provide Accelerator produced Ac225 for radiotherapy: 2017 Update June 21, 2017

TAT-10: Production of a Thorium/Actinium Generator at the Canadian Nuclear Laboratories June 21, 2017

TAT-10: Progress Toward an Alternate Method for Production of Ac-225 June 21, 2017

TAT-10: Radium 223 from Bench to Bedside, and Future Directions for Targeted Alpha Therapy June 21, 2017

Bladder Cancer Academy 2017: Bladder Cancer Biomarkers: New and Old June 13, 2017

Bladder Cancer Academy 2017: Bladder-Sparing Strategies June 13, 2017

Bladder Cancer Academy 2017: Neoadjuvant and Adjuvant Chemotherapy Bladder Cancer June 13, 2017

Bladder Cancer Academy 2017: Genitourinary Oncology: A Peek Over the Horizon June 13, 2017

Bladder Cancer Academy 2017: Immunotherapy of Advanced Bladder Cancer: The Next Frontier June 13, 2017

Bladder Cancer Academy 2017: Immunotherapy of Renal Cell Carcinoma June 13, 2017

Bladder Cancer Academy 2017: Intravesical Therapy: When Bacillus Calmette-Guerin Fails June 13, 2017

Bladder Cancer Academy 2017: AUA Guidelines: Muscle-Invasive Bladder Cancer June 13, 2017

Bladder Cancer Academy 2017: Why LUGPA Embraces Managing Advanced Genitourinary Cancers June 13, 2017

Bladder Cancer Academy 2017: AUA Guidelines: Non-Muscle Invasive Bladder Cancer June 13, 2017

Bladder Cancer Academy 2017: Quality Indicators and Enhanced Imaging in Cystoscope and TURBT June 13, 2017

Bladder Cancer Academy 2017: Targeted Therapies for Renal Cell Carcinoma June 13, 2017

ASCO 2017: Does Prostate Cancer Presentation and Biologic Characteristics Differ in Older Patients? June 6, 2017

ASCO 2017: How Randomized Trials of STAMPEDE Have Influenced Treatment Decisions in the United Kingdom June 6, 2017

ASCO 2017: Physical and Cognitive Effects of Systemic Therapy in Older Men with Prostate Cancer June 6, 2017

Page 397 of 535